000			01517 a2200457 4500
005			20250513041204.0
264		0	_c19950515
008			199505s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aRussell, K J
245	0	0	_aAbrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. _h[electronic resource]
260			_bCancer research _cApr 1995
300			_a1639-42 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma
650	0	4	_aCaffeine _xpharmacology
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCell Line
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDose-Response Relationship, Radiation
650	0	4	_aFlow Cytometry
650	0	4	_aG1 Phase _xdrug effects
650	0	4	_aG2 Phase _xdrug effects
650	0	4	_aGenes, Viral
650	0	4	_aHumans
650	0	4	_aKinetics
650	0	4	_aLung Neoplasms
650	0	4	_aNocodazole _xpharmacology
650	0	4	_aOncogenes
650	0	4	_aPapillomaviridae _xgenetics
650	0	4	_aRadiation-Sensitizing Agents _xpharmacology
650	0	4	_aTime Factors
650	0	4	_aTumor Cells, Cultured
700	1		_aWiens, L W
700	1		_aDemers, G W
700	1		_aGalloway, D A
700	1		_aPlon, S E
700	1		_aGroudine, M
773	0		_tCancer research _gvol. 55 _gno. 8 _gp. 1639-42
999			_c7711856 _d7711856